Below is an excerpt from a complimentary research note by our Healthcare Team of Tom Tobin, William McMahon, and Justin Venneri. We are pleased to announce our new Sector Pro Product Health Care Pro. Click HERE to learn more.
We crossed 100MM doses of SARS-CoV-2 vaccine doses distributed as of the latest CDC update, and President Joe Biden said that we should expect to have enough vaccine doses for all adults by the end of May.
That's a pretty aggressive call, and we're not sure it needed to be made. Regardless, the partnership announced earlier in the day yesterday between Merck (MRK) and Johnson & Johnson (JNJ) to produce the JNJ vaccine is exciting news.
The single shot will certainly help accelerate the pace of vaccinations. Here's our updated target date tracker:
The ADP Employment data looks like it's about to head higher, even without a vaccine tailwind.
The employment and other macro data feed our forecast algorithms, which in concert with the MicroQuads help inform our research and opinions about stocks like $EYE, $JNJ, $HCA, and $USPH, to name a few.